227 related articles for article (PubMed ID: 25060351)
1. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis.
Okada S; Irié T; Tanaka J; Yasuhara R; Yamamoto G; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
J Oral Pathol Med; 2015 Feb; 44(2):115-25. PubMed ID: 25060351
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
Feng Y; Li L; Zhang X; Zhang Y; Liang Y; Lv J; Fan Z; Guo J; Hong T; Ji B; Ji Q; Mei G; Ding L; Zhang S; Xu X; Ye Q
Cancer Sci; 2015 Oct; 106(10):1313-22. PubMed ID: 26211905
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade.
Liu J; Cao W; Chen W; Xu L; Zhang C
J Oral Pathol Med; 2015 Feb; 44(2):109-14. PubMed ID: 25060050
[TBL] [Abstract][Full Text] [Related]
4. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
Chang KW; Chu TH; Gong NR; Chiang WF; Yang CC; Liu CJ; Wu CH; Lin SC
Oral Dis; 2013 Sep; 19(6):611-9. PubMed ID: 23231387
[TBL] [Abstract][Full Text] [Related]
5. The involvement of hematopoietic pre-B cell leukemia transcription factor-interacting protein in regulating epithelial-mesenchymal transition of human spinal glioblastoma.
Wang D; Wang L; Zhou Y; Zhao X; Xiong H
Tumour Biol; 2016 May; 37(5):5897-903. PubMed ID: 26590606
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
7. HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway.
Pan J; Qin Y; Zhang M
Biomed Pharmacother; 2016 Feb; 77():176-81. PubMed ID: 26796282
[TBL] [Abstract][Full Text] [Related]
8. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.
Chen Y; Zhao R; Zhao Q; Shao Y; Zhang S
Oncol Res; 2016; 24(3):153-60. PubMed ID: 27458096
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
11. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
Fang LY; Wong TY; Chiang WF; Chen YL
J Oral Pathol Med; 2010 Apr; 39(4):342-8. PubMed ID: 20040021
[TBL] [Abstract][Full Text] [Related]
12. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
13. Nucleostemin affects the proliferation but not differentiation of oral squamous cell carcinoma cells.
Yoshida R; Fujimoto T; Kudoh S; Nagata M; Nakayama H; Shinohara M; Ito T
Cancer Sci; 2011 Jul; 102(7):1418-23. PubMed ID: 21443540
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
15. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
[TBL] [Abstract][Full Text] [Related]
16. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition.
Xu X; Jiang C; Wang S; Tai Y; Wang T; Kang L; Fan Z; Li S; Li L; Fu J; Liu J; Ji Q; Wang X; Wei L; Ye Q
IUBMB Life; 2013 Oct; 65(10):873-82. PubMed ID: 24038948
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
[TBL] [Abstract][Full Text] [Related]
18. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin 1 promotes invasion and migration by regulating epithelial-to-mesenchymal transition during oral carcinogenesis.
Niu W; Zhang M; Chen H; Wang C; Shi N; Jing X; Ge L; Chen T; Tang X
Oncotarget; 2016 Jul; 7(30):47042-47051. PubMed ID: 27259998
[TBL] [Abstract][Full Text] [Related]
20. Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.
Mikami T; Hada T; Chosa N; Ishisaki A; Mizuki H; Takeda Y
J Oral Pathol Med; 2013 Feb; 42(2):133-9. PubMed ID: 22672247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
